Publications: all consultations

You can use the filters to show only results that match your interests

Filter publications
38 publications by Medicines and Healthcare products Regulatory Agency ×
Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. Proposal to make Colourstart Test 65mcg Cutaneous Patch available from general sales outlets without prescription

    • MHRA
    • Closed consultation
  2. MHRA consultation on EU exit no-deal legislative proposals

    • MHRA
    • Closed consultation
  3. Implementing ‘safety features’ under the Falsified Medicines Directive

    • MHRA
    • Closed consultation
  4. Health institution exemption for IVDR/MDR

    • MHRA
    • Open consultation
  5. Post-implementation Review of the Human Medicines Regulations 2012 (MLX 391)

    • MHRA
    • Consultation outcome
  6. Proposal to make Sildenafil 50mg film-coated tablets available from Pharmacies

    • MHRA
    • Consultation outcome
  7. Strategy for pharmacopoeial public quality standards for biological medicines

    • MHRA
    • Consultation outcome
  8. Proposal to make Dovonex Psoriasis Ointment available from Pharmacies

    • MHRA
    • Consultation outcome
  9. Proposal to make Arthriex 750mg and 1500mg film-coated tablets available from Pharmacies

    • MHRA
    • Consultation outcome
  10. Classification of Nasonex Allergy Control Nasal Spray

    • MHRA
    • Consultation outcome
  11. Reclassification of Otrivine extra dual relief nasal spray solution (ARM 90)

    • MHRA
    • Consultation outcome
  12. Proposal to make Maloff Protect 250mg/100mg film-coated tablets available from Pharmacies

    • MHRA
    • Consultation outcome
  13. Proposal on increases and additions to current medical devices fees

    • MHRA
    • Consultation outcome
  14. Pharmacy dispensing models and displaying prices on medicines

    • DHSC and MHRA
    • Closed consultation
  15. Regulatory fees for e-cigarettes

    • MHRA
    • Consultation outcome
  16. Classification of Ibuprofen Seven Plus 200mg/5ml Oral Suspension

    • MHRA
    • Closed consultation
  17. Regulatory fees for medicines: 2016 to 2017 and fees for online sellers of medicines

    • MHRA
    • Consultation outcome
  18. Proposal to allow wider access to naloxone for use in emergencies

    • MHRA
    • Closed consultation
  19. British Pharmacopoeia Commission: triennial review

    • DHSC and MHRA
    • Consultation outcome

    First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government

  20. Commission on Human Medicines: triennial review

    • DHSC, MHRA and CHM
    • Consultation outcome

    First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government

  21. Hormonal pregnancy tests: call for evidence

    • MHRA
    • Closed consultation
  22. Classification of Nexium Control 20mg Gastro-Resistant

    • MHRA
    • Consultation outcome
  23. Allowing paramedics involved in helicopter search and rescue operations to administer medicines

    • MHRA
    • Closed consultation
  24. Amendments to the Human Medicines Regulations 2012

    • DHSC and MHRA
    • Consultation outcome

    First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government

  25. Reclassify Soleve Sunburn Relief cutaneous emulsion

    • MHRA
    • Closed consultation
  26. Transfer of responsibility of the certificate of free sales (CFS) to MHRA

    • MHRA
    • Consultation outcome
  27. Proposal to simplify the information requirements for advertising of medicinal products to prescribers and suppliers of medicines (MLX384)

    • MHRA
    • Consultation outcome
  28. Supplying asthma inhalers to schools for emergency use

    • DHSC and MHRA
    • Consultation outcome

    First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government

  29. Safety feature (Falsified Medicines Directive): ‘black’ and ‘white’ lists

    • MHRA
    • Closed consultation
  30. Plans to revoke ‘The Clinical Thermometers Regulations 1993’

    • MHRA
    • Closed consultation
  31. MHRA business engagement assessment - variations processing review

    • MHRA
    • Consultation outcome
  32. Change in classification of Galpharm Period Pain Relief 250mg Gastro-Resistant Tablets (ARM 87)

    • MHRA
    • Closed consultation
  33. Change in legal classification of Nurofen Express 400mg Oral Powder (ARM 86)

    • MHRA
    • Closed consultation
  34. MHRA business engagement assessment on introduction of tell-and-do variations for a specific subset of parallel import licences

    • MHRA
    • Closed consultation
  35. Availability of diclofenac as a pharmacy medicine (MLX 382)

    • MHRA
    • Closed consultation
  36. European Commission's proposal for pharmacovigilance fees payable to the European Medicines Agency

    • DHSC and MHRA
    • Closed consultation

    First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government

  37. Proposal to end sell-through period for unlicensed herbal medicines

    • MHRA
    • Consultation outcome
  38. Classification of Pirinase Hayfever Relief for Adults 0.05% Nasal Spray

    • MHRA
    • Consultation outcome